8-KItem 5.02 · Officer/Director ChangeItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements
Dexcom filed Form 8‑K on Feb 26, 2026: Item 9.01 lists Exhibit 99.1 (press release dated Feb 26, 2026) and…
Filed with the SEC on · Summarized by InvestorsBot
Dexcom filed Form 8‑K on Feb 26, 2026: Item 9.01 lists Exhibit 99.1 (press release dated Feb 26, 2026) and Exhibit 104 (Inline XBRL cover page). Report signed by CFO Jereme M. Sylvain. $DXCM #8K #SEC 📄✍️
Investors: review Exhibit 99.1 attached to the 8‑K for any material corporate or financial updates—this filing provides the official press release and data exhibits. $DXCM #Dexcom #InvestorAlert 🔍📎
8‑K exhibits are available on EDGAR—see the Feb 26, 2026 filing for the full press release and Inline XBRL cover page. Signed by Dexcom CFO Jereme M. Sylvain. $DXCM #DiabetesTech #SEC 🔗💼